Spectrophotometric determination of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors in pharmaceutical preparations

Simple and accurate spectrophotometric methods are presented for the determination of five 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductase inhibitors (statins), namely atorvastatin, fluvastatin, pitavastatin, rosuvastatin, and simvastatin, in pharmaceutical preparations. The methods are based on the reaction of drugs as n-electron donor with 7,7,8,8-tetracyanoquinodimethane as p-acceptors to give highly colored complex species. All variables were studied in order to optimize the reaction conditions. Beer's law was obeyed in the concentration ranges 4--20 m g mL-1, 4--12 m g mL-1, 0.8--2.4 m g mL-1, 4--14 m g mL-1, and 2.5--20 m g mL-1 for atorvastatin, fluvastatin, pitavastatin, rosuvastatin, and simvastatin, respectively. The proposed methods were successfully applied to the pharmaceutical preparations without any interference from excipients.

Spectrophotometric determination of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors in pharmaceutical preparations

Simple and accurate spectrophotometric methods are presented for the determination of five 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductase inhibitors (statins), namely atorvastatin, fluvastatin, pitavastatin, rosuvastatin, and simvastatin, in pharmaceutical preparations. The methods are based on the reaction of drugs as n-electron donor with 7,7,8,8-tetracyanoquinodimethane as p-acceptors to give highly colored complex species. All variables were studied in order to optimize the reaction conditions. Beer's law was obeyed in the concentration ranges 4--20 m g mL-1, 4--12 m g mL-1, 0.8--2.4 m g mL-1, 4--14 m g mL-1, and 2.5--20 m g mL-1 for atorvastatin, fluvastatin, pitavastatin, rosuvastatin, and simvastatin, respectively. The proposed methods were successfully applied to the pharmaceutical preparations without any interference from excipients.

___

  • m etho d s fo r th e assa y o f d rugs (n =5 ). Tobert, J. A. Nat. Rev. Drug Discov. 2003, 2, 517–526.
  • Jones, P. H.; Davidson, M. H.; Stein, E. A.; Bays, H. E.; McKenney, J. M.; Miller, E. Am. J. Cardiol. 2003, 92, 152–160.
  • Caslake, M. J.; Stewart, G.; Day, S. P.; Daly, E. Atherosclerosis 2003, 171, 245–253.
  • Endo, A. J. Lipid Res 1992, 33 1569–1582.
  • Erturk, S.; Onal, A.; C ¸ etin, S. M. J. Chromatogr. B 2003, 793, 193–205.
  • Sweetman, S. C. Martindale: The Complete Drug Reference, 34th Ed., Pharmaceutical Press, London, 2004.
  • Terata, Y.; Saito, T.; Fujiwara, Y.; Hasegawa, H.; Miura, H.; Watanabe, H.; Chiba, Y.; Kibira, S.; Miura, M. Pharmacology 2003, 68, 169–176.
  • Lennernas, H.; Fager, G. Clin Pharmacokinet. 1997, 32 403–425.
  • Nagaraju, P.; Pasumarthy; Gopal, N. V.; Srinivas, V. D. N.; Padma, S. V. N. Asian J. Res. Chem. 2008, 1, 64–66. Erk, N. Anal. Lett. 2003, 36, 2699–2711.
  • Nagaraj; Vipul K.; Rajshree, M. Anal. Sci. 2007, 23, 445–451.
  • Stanisz, B.; Rafa, W. Chem. Anal-Warsaw 2008, 53, 417–428.
  • Ashour, S.; Bahbouh, M.; Khateeb, M Int. J. Biomed. Sci. 2010, 6, 19–26.
  • Saminathan, J.; Ksankar, A. S.; Anandakumar, K.; Vetrichelvan, T. E-J. Chem. 2009, 6, 1233–1239.
  • Erk, N. Phamazie 2002, 57, 817–819.
  • Moussa, B. A.; Mohamed, M. F.; Youssef, N. F. Eur. J. Chem. 2010, 1, 348–351.
  • Wang, L.; Asgharnejad, M. J. Pharmaceut. Biomed. 2000, 21, 1243–1248.
  • Gupta, A.; Mishra, P.; Shah, K. E-J. Chem. 2009, 6, 89–92.
  • Krishna, M. V.; Sankar, D. G. E-J. Chem. 2007, 4, 272–278.
  • Sankar, G. D.; Babu, J. P.; Kumar, A. B.; Krishna, V. M. Acta Cienc. Indica, Ser. Chem. 2007, 33, 1–4.
  • Gomes, F.; Garcia, P.; Alves, J.; Singh, A.; Kedor-Hackmann, E.; Santoro, M. Anal. Lett. 2009, 42, 1784–1804.
  • Altuntas, T. G.; Erk, N. J. Liq. Chromatogr. R. T. 2004, 27, 83–93.
  • Pasha, M. K.; Muzeeb, S.; Basha, S. J. S.; Shashikumar, D.; Mullangi, R.; Srinivas, N. R. Biomed. Chromatogr. 2006 20, 282–293.
  • Seshachalam, U.; Kothapally, C. B. J. Liq. Chromatogr. R. T. 2008, 31, 714–721.
  • Vuletic, M.; Cindric, M.; Kouznjak, J. D. J. Pharmaceut. Biomed. 2005, 37, 715–721.
  • Carlucci, G.; Mazzeo, P. J. Pharmaceut. Biomed. 1992, 10 693–697.
  • Ochiai, H.; Chiyama, N. K.; Imagaki, S. J. Chromatogr. B 1997, 694, 211–217.
  • Abdallah, O. M. E-J. Chem. 2011, 8(2), 753–761.
  • Kaila, H. O.; Ambasana, M. A.; Thakkar, R. S.; Saravaia, H. T.; Shah, A. K. Indian J. Pharm. Sci. 2010, 72, 592–598.
  • Kumar, N. S.; Nisha, N.; Nirmal, J.; Sonali, N.; Bagyalakshmi, J. Pharm. Anal. Acta 2011, 2, 1–4.
  • Sane, R. T.; Kamat, S. S.; Menon, S. N.; Inamdar, S. R.; Mote, M. R. J. Planar Chromatogr. -Mod. TLC 2005, 18, 194–198.
  • Yadav, S.; Mhaske, D.; Kakad, A.; Patil, B.; Kadam, S.; Dhaneshwar, S. Indian J. Pharm. Sci. 2005, 67, 182–186. Erk, N. Crit. Rev. Anal. Chem. 2004, 34, 1–7.
  • Dogan-Topal, B.; Uslu, B.; ¨ Ozkan, S. A. Comb. Chem. High T. Scr. 2007, 10, 571–582.
  • Saleh, G. A. Talanta 1998, 46, 111–121.
  • Kovar, K. A.; Abdel-Hamid, M. E. Arch. Pharm. 1984, 317, 246–250.
  • Foster, R. Organic Charge-Transfer Complexes, Academic Press, London, 1969.
  • Melby, L. R.; Patai, S. The Chemistry of the Cyano Group, Interscience, New York, 1970.
  • Rao, C. N. R.; Bhat, S. N.; Dwivedi, P. C. Applied Spectroscopy Reviews, 5, Brame, E.D., ed, Marcel Dekker, New York, 1972.
  • Kovar, K. A.; Mayer, W.; Auterhoff, H. Arch. Pharm. 1981, 314, 447–458.
  • Abdellatef, H. E. J. Pharmaceut. Biomed. 1998, 17, 1267–1271.
  • Saleh, G. A.; Askal, H. F.; Darwish, L. A.; El-Shorbagi, A. N. A. Anal. Sci. 2003, 19, 281-287.
  • Abdel-Gawad, F. M.; Issa, Y. M.; Fahmy, H. M.; Hussein, H. M. Microchim. Acta 1998, 130, 35–40.
  • Hussein, S. A.; Mohamed, A. M.; Abdel-Alim, M. Analyst 1989, 114, 1129–1131.
  • Job, P. Anal. Chem. 1928, 9, 113–203.
  • ICH, Q2 (R1), Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology, International Conference on Harmonization, Geneva, 2005.
  • United States Pharmacopoeia National Formulary, USP 30-NF 25, United States Pharmacopoeia Convention Inc., Rockville, Maryland, USA; 2007.
  • United States Pharmacopoeia National Formulary, USP 32-NF 27, United States Pharmacopoeia Convention Inc., Rockville, Maryland, USA; 2009.
Turkish Journal of Chemistry-Cover
  • ISSN: 1300-0527
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Spectrophotometric determination of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors in pharmaceutical preparations

Gamze ERGİN, Sena ÇAĞLAR, Armağan ÖNAL, Sıdıka Ertürk TOKER

Ionic liquid mediated synthesis, reactions, and insecticidal activity of 1-[(1H-benzoimidazol-2-yl)amino]spiro[azetidine-4,4 '-[4' H]chroman]-2-ones

Kanti SHARMA, Renuka JAIN

Removal of Cr(III) and Cu(II) using poly(2-chloroaniline)/polyvinylidene uoride composite cation-exchange membranes by Donnan dialysis

Tuğba Sardohan KÖSEOĞLU, Esengül KIR, Sabriye Perçin ÖZKORUCUKLU, Esin KARAMIZRAK

Synthesis and characterization of thermally stable camphor-based polyimide--clay nanocomposites

Murat YİĞİT, Turgay SEÇKİN, Beyhan YİĞİT, Süleyman KÖYTEPE

A one-pot strategy for regioselective synthesis of 6-aryl-3-oxo-2,3-dihydropyridazine-4-carbohydrazides

Mehdi RIMAZ, Hossein MOUSAVI

An efficient ligand-free method for the transfer hydrogenation of ketones and aldehydes catalyzed by different complexes

Sedat YAŞAR, Suzan ÇEKİRDEK, Nilay Akkuş TAŞ

Removal of Cr(III) and Cu(II) using oly(2-chloroaniline)/polyvinylidenefluoride composite cation-exchange membranes by Donnan dialysis

Esengül KIR, Sabriye Perçin ÖZKORUCUKLU

Study on crystal transformation process of magnesium carbonate hydrate based on salt lake magnesium resource utilization

Juan DU, Zhen CHEN, Yu-long WU, Ming-de YANG

Synthesis and antimicrobial investigation of some 5H-pyridazino[4,5-b]indoles

İlker AVAN, Alaattin GÜVEN, Kıymet GÜVEN

Antimicrobial activity and chemical composition of the essential oils of mosses (Hylocomium splendens (Hedw.) Schimp. and Leucodon sciuroides (Hedw.) Schwägr.) growing in Turkey

Tayyibe Beyza CANSU, Büşra YAYLI, Turan ÖZDEMİR, Nevzat BATAN